echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > Beware of monopolies! Drug price behavior

    Beware of monopolies! Drug price behavior

    • Last Update: 2019-11-11
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Manchester United striker The pharmaceutical industry has always been the focus of anti-monopoly law enforcement In the first half of this year, according to relevant media reports, the price of nitroglycerin tablets, which used to be less than 5 yuan per bottle, has recently skyrocketed to nearly 50 yuan per bottle Since this year, the price of nitroglycerin tablets has risen sharply and the news of shortage has appeared As a "life-saving drug" for patients with cardiovascular diseases, the sharp price rise and shortage of nitroglycerin tablets have also attracted great attention of central leaders Relevant parties said, "this is an important issue for people's livelihood To ensure the supply and price stability of drugs, we must not cut off the supply and increase the price arbitrarily." On August 22 of this year, Zeng Yixin, deputy director of the national health and Health Commission, pointed out at the regular briefing held by the new office on measures to strengthen the supply guarantee and price stabilization of commonly used drugs, that in the future, the problem of drug shortage will be solved by improving the purchase policy of short drugs, seriously investigating and punishing the illegal behaviors such as monopoly of APIs and market manipulation For pharmaceutical enterprises, antitrust seems to be a strange term Since the current anti monopoly law of the people's Republic of China came into force on August 1, 2008, it has played an important role in preventing and stopping monopoly behavior, protecting fair competition in the market, improving the efficiency of economic operation, safeguarding the interests of consumers and social public interests, and promoting the healthy development of the socialist market economy At the beginning of 2018, the State Administration of market supervision was established As a unified anti-monopoly law enforcement agency in China, the General Administration of market supervision has replaced the anti-monopoly law enforcement system of three departments (the Ministry of Commerce, the national development and Reform Commission, and the State Administration for Industry and Commerce) The Anti-monopoly Bureau under the General Administration of market supervision has assumed the respective functions of the Ministry of Commerce, the national development and Reform Commission and the State Administration for Industry and commerce Then, what are the main types of monopolies? The author summarizes them as follows Monopoly is mainly divided into horizontal monopoly and vertical monopoly Horizontal monopoly refers to the horizontal alliance of many enterprises in the same industry to achieve market advantage and to eliminate and restrict competition Vertical monopoly refers to the behavior of eliminating and restricting competition between businesses in different economic levels without direct competition in the same industry or brand through some combination, the most common form of which is the producer manipulating the price of resale products of downstream distributors In order to let you have a clearer understanding of the difference between horizontal monopoly and vertical monopoly, we hereby give an example based on relevant information: a certain API is exclusively produced by plant a, and in order to obtain the exclusive right, enterprise B signed the agency sales agreement with plant a, monopolizing the domestic sales of the API The contents of the agreement are as follows: Company B acts as the sole agent for the domestic sales of API produced by company A only with the consent of company B, can factory a supply the API to other manufacturers During this period, enterprise C found enterprise B and wanted to buy APIs Enterprise B requires: the actual market price of finished drugs must be increased by more than n times, and the profits should be shared Since enterprise C did not agree, enterprise B increased the sales price of the API by dozens of times Obviously, B enterprises control the supply of A factories, and B enterprises has the final say to supply C enterprises or not, that is, vertical monopoly For the monopolist, it should be vertical monopoly to force the downstream operators to comply with their trading conditions and control the source of goods by taking advantage of their superior position and threatening to interrupt the supply! However, the unreasonable demand of enterprise B for factory C to raise price and redistribute profit belongs to horizontal monopoly According to relevant data, horizontal monopoly includes: fixed price, market division, joint production reduction, joint boycott, etc But in the above B enterprise raises the price, thus carries on the product control to the C factory, belongs to the horizontal Monopoly! For pharmaceutical enterprises, they often issue price control requirements to agents, and manage agents through price The original intention of pharmaceutical enterprises is to encourage competition among agents and avoid killing the market competition environment with the lowest price At the same time, limiting the minimum price, on the one hand, can ensure the profit of agents, on the other hand, it can also help regulate the market and prevent agents from "fleeing goods" Therefore, in the actual normative behavior, many people think that it is common to not allow sales below a certain price, but from the perspective of anti-monopoly, it is suspected of monopoly.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.